Cargando…

Fatal pulmonary hemorrhage after taking anticoagulation medication

We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also...

Descripción completa

Detalles Bibliográficos
Autor principal: Hammar, Samuel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501539/
https://www.ncbi.nlm.nih.gov/pubmed/26236607
http://dx.doi.org/10.1016/j.rmcr.2015.05.010
_version_ 1782381082822311936
author Hammar, Samuel P.
author_facet Hammar, Samuel P.
author_sort Hammar, Samuel P.
collection PubMed
description We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto(®) (rivaroxaban).
format Online
Article
Text
id pubmed-4501539
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-45015392015-08-01 Fatal pulmonary hemorrhage after taking anticoagulation medication Hammar, Samuel P. Respir Med Case Rep Case Report We describe a 64-year-old man with extensive diffuse acute lung hemorrhage, presumably as a result of anticoagulation therapy. We evaluated reports in the literature concerning acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. We also evaluated autopsy tissue in this case in order to determine the cause of death in this 64-year-old man, who was initially thought to have an asbestos-related disease. Based on the autopsy findings, this man died as a result of anticoagulation therapy; specifically, the use of Xarelto(®) (rivaroxaban). Elsevier 2015-05-22 /pmc/articles/PMC4501539/ /pubmed/26236607 http://dx.doi.org/10.1016/j.rmcr.2015.05.010 Text en © 2015 The Author http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Hammar, Samuel P.
Fatal pulmonary hemorrhage after taking anticoagulation medication
title Fatal pulmonary hemorrhage after taking anticoagulation medication
title_full Fatal pulmonary hemorrhage after taking anticoagulation medication
title_fullStr Fatal pulmonary hemorrhage after taking anticoagulation medication
title_full_unstemmed Fatal pulmonary hemorrhage after taking anticoagulation medication
title_short Fatal pulmonary hemorrhage after taking anticoagulation medication
title_sort fatal pulmonary hemorrhage after taking anticoagulation medication
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501539/
https://www.ncbi.nlm.nih.gov/pubmed/26236607
http://dx.doi.org/10.1016/j.rmcr.2015.05.010
work_keys_str_mv AT hammarsamuelp fatalpulmonaryhemorrhageaftertakinganticoagulationmedication